Indication
Xerostomia secondary to Sjogren's syndrome
Xerostomia secondary to Sjögren's syndrome refers to the subjective sensation and clinical state of oral dryness arising directly from Sjögren's syndrome, a chronic systemic autoimmune exocrinopathy that disproportionately affects women. Read more about Xerostomia secondary to Sjogren's syndrome
36 drugs 30 manufacturers
Drugs that treat it
Common Xerostomia secondary to Sjogren's syndrome therapies.
CEVIMELINE HCL
SALAGEN (PILOCARPINE) (pilocarpine HCl)
EVOXAC (cevimeline HCl)
PILOCARPINE HCL
PILOCARPINE HCL
SALAGEN (pilocarpine HCl)
PILOCARPINE HCL
CEVIMELINE HCL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonXerostomia secondary to Sjögren's syndrome refers to the subjective sensation and clinical state of oral dryness arising directly from Sjögren's syndrome, a chronic systemic autoimmune exocrinopathy that disproportionately affects women.
It is characterized pathologically by progressive lymphocytic infiltration, chronic inflammation, and subsequent destruction and fibrosis of salivary acinar epithelial tissue.
This immune-mediated exocrine destruction markedly impairs salivary secretion, resulting in chronic hyposalivation.
Clinically, affected individuals experience a persistent cotton-mouthed sensation, dysphagia, dysgeusia, and speech difficulties, alongside a heightened vulnerability to dental caries and opportunistic oral infections.
- nih.gov
Xerostomia secondary to Sjögren's syndrome refers to the subjective sensation and clinical state of oral dryness arising directly from Sjögren's syndrome, a chronic systemic autoimmune exocrinopathy that disproportionately affects women It is characterized pathologically by progressive lymphocytic infiltration, chronic inflammation, and subsequent destruction and fibrosis of salivary acinar epithelial tissue
- ada.org
Xerostomia secondary to Sjögren's syndrome refers to the subjective sensation and clinical state of oral dryness arising directly from Sjögren's syndrome, a chronic systemic autoimmune exocrinopathy that disproportionately affects women It is characterized pathologically by progressive lymphocytic infiltration, chronic inflammation, and subsequent destruction and fibrosis of salivary acinar epithelial tissue This immune-mediated exocrine destruction markedly impairs salivary secretion, resulting...
- nih.gov
This immune-mediated exocrine destruction markedly impairs salivary secretion, resulting in chronic hyposalivation
- nih.gov
Clinically, affected individuals experience a persistent cotton-mouthed sensation, dysphagia, dysgeusia, and speech difficulties, alongside a heightened vulnerability to dental caries and opportunistic oral infections
- mayoclinic.org
Clinically, affected individuals experience a persistent cotton-mouthed sensation, dysphagia, dysgeusia, and speech difficulties, alongside a heightened vulnerability to dental caries and opportunistic oral infections
- nih.gov
Clinically, affected individuals experience a persistent cotton-mouthed sensation, dysphagia, dysgeusia, and speech difficulties, alongside a heightened vulnerability to dental caries and opportunistic oral infections
Personalize your experience
Follow Xerostomia secondary to Sjogren's syndrome and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.